The vascular endothelium is a biologically active monolayer of cells provid
ing an interface between the blood how and tissues. Vascular Endothelial Ce
lls (VEC) have two functional states. The endothelium is normally anti-thro
mbotic and anti-adhesive to ensure blood fluidity. During aggressions, such
as atherosclerosis, inflammation states, metabolic diseases (through chemi
cal or mechanical stimuli), VEC can reverse its functions by expressing sto
red material or by slower involvement of previously are repressed genes.
Endothelial cells have three types of anti-thrombotic properties: vase regu
lating properties: VEC release vasomotor components, such as endothelin (va
soconstriction), prostacyclin and nitric oxide (vasodilatation).
Endothelial cells also have antithrombotic and hemostatic properties. They
express proteoglycans on their surface, including some negative-charge, pla
sminogen, sulfate glycoaminoglycans (heparane-sulfate), and secrete plasmin
ogen tissular activator (t-PA) and tissular factor inhibitor. One fundament
al action of the endothelium in that area is the production and expression
of thrombomodulin, a thrombin receptor. This function has a major anticoagu
lation effect, controlling continual thrombin generation at the sub-endothe
lium and blood cell interface. Moreover, endothelial cells show anti-adhesi
on properties. During cardio-vascular diseases, all of these properties may
be reversed.
Thus, the VEC have a determinant role in hemodynamic control through these
various metabolic activities, such as control of homeostasis, vascular tone
, blood fluidity, coagulating properties, cellular adhesion. Otherwise, man
y studies have demonstrated that local blood how conditions have a crucial
role on the VEC properties (mechanoactivation and mechanotransduction conce
pt). In conclusion, knowledge of all the properties of the endothelial cell
s and control of the phenomena which define their functions is a key elemen
t in understanding cardiovascular diseases.